Nexora Pharma CJC-1295 (Without DAC) 5mg
Nexora Pharma CJC-1295 (Without DAC) 5mg is a synthetic analog of growth hormone-releasing hormone (GHRH), also known as Mod GRF 1-29. Researched extensively for its role in stimulating endogenous growth hormone secretion through GHRH receptor activation, without the extended half-life modification of the DAC variant. This peptide demonstrates notable activity in preclinical models examining pulsatile GH release, IGF-1 production, and metabolic/recovery research applications. Lab verified 99%+ purity.
20 units available · For Research Use Only
Scientific Overview
CJC-1295 without DAC is a synthetic analogue of growth hormone-releasing hormone (GHRH), also known as Mod GRF 1-29. It is designed to stimulate endogenous growth hormone secretion by activating the GHRH receptor, without the extended half-life modification seen in the DAC variant. Preclinical models have explored its effects on pulsatile GH release, IGF-1 production, and metabolic and recovery processes. This peptide is lab verified for 99%+ purity, ensuring reliability in research applications.
Research Applications
- GH pulsatility research
- IGF-1 production studies
- Metabolic research applications
- Recovery process exploration
Dosage Information
Reconstitute using bacteriostatic water. Store at -20°C for maximum stability. Ensure solutions are used within 30 days after reconstitution. For research use only, not for human consumption.